What does VLEUGELS PHARMACEUTICAL SERVICES do?

VLEUGELS PHARMACEUTICAL SERVICES is filed with the CBE under the catch-all “Overige zakelijke dienstverlening”. Also registered: pharmacy. Private Limited, started on 1 April 2022, 1 establishment.

What is the address of VLEUGELS PHARMACEUTICAL SERVICES?

The registered office of VLEUGELS PHARMACEUTICAL SERVICES is located at Miksebeekstraat 59, 2930 Brasschaat.

Is VLEUGELS PHARMACEUTICAL SERVICES still active?

Yes. According to the CBE (1 October 2026) VLEUGELS PHARMACEUTICAL SERVICES is active, legal situation “Normale toestand”, started on 1 April 2022.

Is VLEUGELS PHARMACEUTICAL SERVICES registered on Peppol?

Yes, VLEUGELS PHARMACEUTICAL SERVICES is registered on the Peppol network with ID 0208:0784357440.

What is the enterprise number of VLEUGELS PHARMACEUTICAL SERVICES?

The enterprise number of VLEUGELS PHARMACEUTICAL SERVICES is BE0784357440.

When was VLEUGELS PHARMACEUTICAL SERVICES founded?

VLEUGELS PHARMACEUTICAL SERVICES was founded on 1 April 2022.

Who are the directors of VLEUGELS PHARMACEUTICAL SERVICES?

According to the 2025 annual accounts, the directors of VLEUGELS PHARMACEUTICAL SERVICES are: Tinneke Vleugels.

Is VLEUGELS PHARMACEUTICAL SERVICES a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 April 2022; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did VLEUGELS PHARMACEUTICAL SERVICES make in 2025?

VLEUGELS PHARMACEUTICAL SERVICES posted a profit after taxes of € 20,020 in financial year 2025.

What is the revenue of VLEUGELS PHARMACEUTICAL SERVICES?

As a small company, VLEUGELS PHARMACEUTICAL SERVICES is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 28,020.

VLEUGELS PHARMACEUTICAL SERVICES (Private Limited)

Dossier VLEUGELS PHARMACEUTICAL SERVICES, printed on 1 October 2026 from databakkes.be/en/0784357440/vleugels-pharmaceutical-services. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

VLEUGELS PHARMACEUTICAL SERVICES from Brasschaat, company number BE0784357440, closed financial year 2025 with a result of € 20,020 after tax. For that financial year VLEUGELS PHARMACEUTICAL SERVICES recorded a gross margin of € 28,020 and equity of € 1,000. Compared with financial year 2024, the result moved from € 6,982 to € 20,020. Profitable, and profit is growing. The buffer shrank hard: equity is 96 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Shrank hard

€ 1,000

▼ 96% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 20,020

▲ 187% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 19,191

▼ 24% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 42,163 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 3,465

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 892

▲ 16% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 10,258

▲ 21% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 11,360 Gross margin 2022: € 11,360 First fiscal year in the series	€ 10,713 Gross margin 2023: € 10,713 ▼ 6% vs 2022 (€ 11,360) Unfavourable step	€ 11,128 Gross margin 2024: € 11,128 ▲ 4% vs 2023 (€ 10,713) Favourable step	€ 28,020 Gross margin 2025: € 28,020 ▲ 152% vs 2024 (€ 11,128) Favourable step	▲ 152%
Profit after taxes	€ 8,440 Profit after taxes 2022: € 8,440 First fiscal year in the series	€ 6,722 Profit after taxes 2023: € 6,722 ▼ 20% vs 2022 (€ 8,440) Unfavourable step	€ 6,982 Profit after taxes 2024: € 6,982 ▲ 4% vs 2023 (€ 6,722) Favourable step	€ 20,020 Profit after taxes 2025: € 20,020 ▲ 187% vs 2024 (€ 6,982) Favourable step	▲ 187%
Equity	€ 9,440 Equity 2022: € 9,440 First fiscal year in the series	€ 16,162 Equity 2023: € 16,162 ▲ 71% vs 2022 (€ 9,440) Favourable step	€ 23,143 Equity 2024: € 23,143 ▲ 43% vs 2023 (€ 16,162) Favourable step	€ 1,000 Equity 2025: € 1,000 ▼ 96% vs 2024 (€ 23,143) Unfavourable step	▼ 96%
Total debts	€ 12,693 Total debts 2022: € 12,693 First fiscal year in the series	€ 22,476 Total debts 2023: € 22,476 ▲ 77% vs 2022 (€ 12,693) Unfavourable step	€ 11,516 Total debts 2024: € 11,516 ▼ 49% vs 2023 (€ 22,476) Favourable step	€ 36,638 Total debts 2025: € 36,638 ▲ 218% vs 2024 (€ 11,516) Unfavourable step	▲ 218%
Cash	€ 14,493 Cash 2022: € 14,493 First fiscal year in the series	€ 19,261 Cash 2023: € 19,261 ▲ 33% vs 2022 (€ 14,493) Favourable step	€ 25,409 Cash 2024: € 25,409 ▲ 32% vs 2023 (€ 19,261) Favourable step	€ 19,191 Cash 2025: € 19,191 ▼ 24% vs 2024 (€ 25,409) Unfavourable step	▼ 24%
Retained profit	€ 8,440 Retained profit 2022: € 8,440 First fiscal year in the series	€ 15,162 Retained profit 2023: € 15,162 ▲ 80% vs 2022 (€ 8,440) Favourable step	€ 22,143 Retained profit 2024: € 22,143 ▲ 46% vs 2023 (€ 15,162) Favourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 22,143) Unfavourable step	▼ 100%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 42,163 Dividend 2025: € 42,163 Unchanged (€ 0) Unchanged
Balance sheet total	€ 22,133 Balance sheet total 2022: € 22,133 First fiscal year in the series	€ 38,637 Balance sheet total 2023: € 38,637 ▲ 75% vs 2022 (€ 22,133) Unchanged	€ 34,659 Balance sheet total 2024: € 34,659 ▼ 10% vs 2023 (€ 38,637) Unchanged	€ 37,638 Balance sheet total 2025: € 37,638 ▲ 9% vs 2024 (€ 34,659) Unchanged	▲ 9%

Key figures of VLEUGELS PHARMACEUTICAL SERVICES, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to VLEUGELS PHARMACEUTICAL SERVICES?

What happened at VLEUGELS PHARMACEUTICAL SERVICES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: profit of € 20,020 (▲ 187% vs 2024). Source: NBB ↗
May 1, 2022 New establishment in Brasschaat. KBO
2022 Tinneke Vleugels became a director. NBB
Apr 1, 2022 Start of the company according to the CBE. KBO

In short

From € 8,440 profit in 2022 to € 20,020 profit in 2025.

Paid € 13,815 in corporate taxes since 2022.

Best year ever: 2025, with € 20,020 profit.

Paid out € 42,163 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at VLEUGELS PHARMACEUTICAL SERVICES? We notify you, reason included.

Follow VLEUGELS PHARMACEUTICAL SERVICES

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Tinneke Vleugels

VLEUGELS PHARMACEUTICAL SERVICES

Behind VLEUGELS PHARMACEUTICAL SERVICES is Tinneke Vleugels.

See the full network in the app

Directors

According to the 2025 annual accounts

Tinneke Vleugels

Director

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Miksebeekstraat 59

2930 Brasschaat

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0784.357.440

VAT number

BE 0784.357.440

Registered office

Miksebeekstraat 59, 2930 Brasschaat

Names & denominations

VLEUGELS PHARMACEUTICAL SERVICES · VPS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 April 2022

Peppol

Active · Active since 1 Dec 2025

Activities · NACE

Overige zakelijke dienstverlening, neg

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗